1
|
Cekic S, Cicek F, Karali Y, Gorukmez O, Eren E, Kilic SS. Three different faces of TACI mutations. Scand J Immunol 2020; 91:e12879. [PMID: 32160337 DOI: 10.1111/sji.12879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2019] [Revised: 03/06/2020] [Accepted: 03/08/2020] [Indexed: 12/01/2022]
Affiliation(s)
- Sukru Cekic
- Division of Pediatric Allergy and Clinical Immunology, Uludag University Faculty of Medicine, Bursa, Turkey
| | - Fatih Cicek
- Division of Pediatric Allergy and Clinical Immunology, Uludag University Faculty of Medicine, Bursa, Turkey
| | - Yasin Karali
- Division of Pediatric Allergy and Clinical Immunology, Uludag University Faculty of Medicine, Bursa, Turkey
| | - Orhan Gorukmez
- Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey
| | - Erdal Eren
- Division of Pediatric Endocrinology, Uludag University Faculty of Medicine, Bursa, Turkey
| | - Sara Sebnem Kilic
- Division of Pediatric Allergy and Clinical Immunology, Uludag University Faculty of Medicine, Bursa, Turkey
| |
Collapse
|
2
|
Coopmans EC, Chunharojrith P, Neggers SJCMM, van der Ent MW, Swagemakers SMA, Hollink IH, Barendregt BH, van der Spek PJ, van der Lely AJ, van Hagen PM, Dalm VASH. Endocrine Disorders Are Prominent Clinical Features in Patients With Primary Antibody Deficiencies. Front Immunol 2019; 10:2079. [PMID: 31543881 PMCID: PMC6730260 DOI: 10.3389/fimmu.2019.02079] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2019] [Accepted: 08/16/2019] [Indexed: 01/14/2023] Open
Abstract
Background: Primary antibody deficiencies (PADs) and anterior pituitary dysfunction are both rare conditions. However, recent studies have remarkably reported the occurrence of anterior pituitary dysfunction in PAD patients. Methods: In this cross-sectional, single-center study we evaluated the prevalence of endocrine disorders in adult PAD patients. Our study focused on common variable immunodeficiency (CVID), immunoglobulin G (IgG) subclass deficiency (IgGSD), and specific anti-polysaccharide antibody deficiency (SPAD). We assessed hormone levels, performed provocative tests and genetic testing in a subset of patients by direct sequencing of the nuclear factor kappa beta subunit 2 (NFKB2) gene and primary immunodeficiency (PID) gene panel testing by whole exome sequencing (WES). Results: Our results demonstrated that one out of 24 IgGSD/SPAD patients had secondary hypothyroidism and three out of 9 men with IgGSD/SPAD had secondary hypogonadism. Premature ovarian failure was observed in four out of 9 women with CVID and primary testicular failure in one out of 15 men with CVID. In two out of 26 CVID patients we found partial adrenal insufficiency (AI) and in one out of 18 patients with IgGSD/SPAD secondary AI was found. Moreover, in one out of 23 patients with CVID and in two out of 17 patients with IgGSD/SPAD severe growth hormone deficiency (GHD) was found, while one patient with IgGSD/SPAD showed mild GHD. Combined endocrine disorders were detected in two women with CVID (either partial secondary AI or autoimmune thyroiditis with primary hypogonadism) and in three men with IgGSD/SPAD (two with either mild GHD or secondary hypothyroidism combined with secondary hypogonadism, and one man with secondary AI and severe GHD). Genetic testing in a subset of patients did not reveal pathogenic variants in NFKB2 or other known PID-associated genes. Conclusion: This is the first study to describe a high prevalence of both anterior pituitary and end-organ endocrine dysfunction in adult PAD patients. As these endocrine disorders may cause considerable health burden, assessment of endocrine axes should be considered in PAD patients.
Collapse
Affiliation(s)
- Eva C. Coopmans
- Endocrinology Section, Department of Internal Medicine, Pituitary Centre Rotterdam, Erasmus University Medical Centre, Rotterdam, Netherlands
- Academic Center for Rare Immunological Diseases (RIDC), Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands
| | - Paweena Chunharojrith
- Academic Center for Rare Immunological Diseases (RIDC), Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands
- Division of Clinical Immunology, Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, Netherlands
- Department of Endocrinology, Mahidol University, Bangkok, Thailand
| | - Sebastian J. C. M. M. Neggers
- Endocrinology Section, Department of Internal Medicine, Pituitary Centre Rotterdam, Erasmus University Medical Centre, Rotterdam, Netherlands
| | - Marianne W. van der Ent
- Academic Center for Rare Immunological Diseases (RIDC), Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands
- Division of Clinical Immunology, Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, Netherlands
| | - Sigrid M. A. Swagemakers
- Academic Center for Rare Immunological Diseases (RIDC), Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands
- Department of Pathology and Clinical Bioinformatics, Erasmus University Medical Centre, Rotterdam, Netherlands
| | - Iris H. Hollink
- Department of Clinical Genetics, Erasmus University Medical Centre, Rotterdam, Netherlands
| | - Barbara H. Barendregt
- Academic Center for Rare Immunological Diseases (RIDC), Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands
- Department of Immunology, Erasmus University Medical Centre, Rotterdam, Netherlands
| | - Peter J. van der Spek
- Academic Center for Rare Immunological Diseases (RIDC), Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands
- Department of Pathology and Clinical Bioinformatics, Erasmus University Medical Centre, Rotterdam, Netherlands
| | - Aart-Jan van der Lely
- Endocrinology Section, Department of Internal Medicine, Pituitary Centre Rotterdam, Erasmus University Medical Centre, Rotterdam, Netherlands
| | - P. Martin van Hagen
- Academic Center for Rare Immunological Diseases (RIDC), Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands
- Division of Clinical Immunology, Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, Netherlands
- Department of Immunology, Erasmus University Medical Centre, Rotterdam, Netherlands
| | - Virgil A. S. H. Dalm
- Academic Center for Rare Immunological Diseases (RIDC), Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands
- Division of Clinical Immunology, Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, Netherlands
- Department of Immunology, Erasmus University Medical Centre, Rotterdam, Netherlands
| |
Collapse
|